Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapy.

Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapy.
J Dermatolog Treat. 2019 Nov 05;:1-5
Authors: Chat VS, Kearns DG, Uppal SK, Wu JJ
PMID: 31689137 [PubMed - as supplied by publisher]

Source: Journal of Dermatological Treatment - November 9, 2019 Category: Dermatology Tags: J Dermatolog Treat Source Type: research